Reference
Borlenghi E, et al. Efficacy and safety of decitabine as first-line therapy for elderly patients with acute myeloid leukemia.a real life multicentric experience of the northern Italy. Blood 130 (Suppl. 1): 1315, Dec 2017. Available from: URL: http://www.bloodjournal.org/content/130/Suppl_1/1315 [abstract] - Italy
Rights and permissions
About this article
Cite this article
Decitabine. Reactions Weekly 1695, 149 (2018). https://doi.org/10.1007/s40278-018-43976-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-018-43976-8